[Federal Register Volume 72, Number 67 (Monday, April 9, 2007)]
[Notices]
[Page 17591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-6638]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[License No. 09/79-0398]


Sorrento Growth Partners I, L.P.; Notice Seeking Exemption Under 
Section 312 of the Small Business Investment Act, Conflicts of Interest

    Notice is hereby given that Sorrento Growth Partners I, L.P., 4370 
La Jolla Village Drive, Suite 1040, San Diego, CA 92122, a Federal 
Licensee under the Small Business Investment Act of 1958, as amended 
(``the Act''), in connection with the financing of a small concern, has 
sought an exemption under Section 312 of the Act and Section 107.730, 
Financings which Constitute Conflicts of Interest of the Small Business 
Administration (``SBA'') Rules and Regulations (13 CFR 107.730 (2006)). 
Sorrento Growth Partners I, L.P. provided debt financing to Perlan 
Therapeutics, Inc., 6310 Nancy Ridge Drive, Suite 102, San Diego, CA 
92121. The financing is contemplated for operating expenses and general 
corporate purposes.
    The financing is brought within the purview of Sec.  107.730(a)(1) 
of the Regulations because three Associates, Sorrento Ventures CE, 
L.P., Sorrento Ventures III, L.P. and Sorrento Ventures IV, L.P., by 
way of common management, collectively own more than ten percent of the 
Company. Therefore, Perlan Therapeutics, Inc. is also considered an 
Associate of Sorrento Growth Partners I, L.P. as defined at 13 CFR 
107.50 of the SBIC Regulations.
    Notice is hereby given that any interested person may submit 
written comments on the transaction to the Associate Administrator for 
Investment, U.S. Small Business Administration, 409 3rd Street, SW., 
Washington, DC 20416.

Jaime Guzmn-Fournier,
Associate Administrator for Investment.
[FR Doc. E7-6638 Filed 4-6-07; 8:45 am]
BILLING CODE 8025-01-P